Kolossváry, Márton
Bluemke, David A.
Fishman, Elliot K.
Gerstenblith, Gary
Celentano, David
Mandler, Raul N.
Khalsa, Jag
Bhatia, Sandeepan
Chen, Shaoguang
Lai, Shenghan https://orcid.org/0000-0003-1340-9609
Lai, Hong
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA12777)
National Institute on Drug Abuse (R01DA15020)
National Institute on Drug Abuse (R01DA25524)
National Institute on Drug Abuse (R01DA035632)
National Institute on Drug Abuse (R21DA048780)
National Institute on Drug Abuse (U01DA040325)
Article History
Received: 15 February 2022
Revised: 5 April 2022
Accepted: 16 May 2022
First Online: 1 June 2022
Declarations
:
: The scientific guarantor of this publication is Shenghan Lai.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: Institutional Review Board approval was obtained.
: Some study subjects or cohorts have been previously reported in Sandfort V, Bluemke DA, Vargas J et al (2017) Coronary Plaque progression and regression in asymptomatic African American chronic cocaine users with obstructive coronary stenoses: a preliminary study. <i>J Addict Med</i> 11:126-137.
: • prospective• observational• performed at one institution